309 related articles for article (PubMed ID: 22731244)
1. Allogeneic serum eye drops for the treatment of dry eye patients with chronic graft-versus-host disease.
Na KS; Kim MS
J Ocul Pharmacol Ther; 2012 Oct; 28(5):479-83. PubMed ID: 22731244
[TBL] [Abstract][Full Text] [Related]
2. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease.
Ogawa Y; Okamoto S; Mori T; Yamada M; Mashima Y; Watanabe R; Kuwana M; Tsubota K; Ikeda Y; Oguchi Y
Bone Marrow Transplant; 2003 Apr; 31(7):579-83. PubMed ID: 12692625
[TBL] [Abstract][Full Text] [Related]
3. A Single-Center Pilot Prospective Study of Topical Application of Platelet-Derived Eye Drops for Patients with Ocular Chronic Graft-versus-Host Disease.
Zallio F; Mazzucco L; Monaco F; Astori MR; Passera R; Drago G; Tamiazzo S; Rapetti M; Dolcino D; Guaschino R; Pini M; Ladetto M
Biol Blood Marrow Transplant; 2016 Sep; 22(9):1664-1670. PubMed ID: 27269196
[TBL] [Abstract][Full Text] [Related]
4. Tear osmolarity in ocular graft-versus-host disease.
Berchicci L; Iuliano L; Miserocchi E; Bandello F; Modorati G
Cornea; 2014 Dec; 33(12):1252-6. PubMed ID: 25343699
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease.
Chiang CC; Lin JM; Chen WL; Tsai YY
Cornea; 2007 Aug; 26(7):861-3. PubMed ID: 17667623
[TBL] [Abstract][Full Text] [Related]
6. [Autologous serum tears: Long-term treatment in dry eye syndrome].
Beylerian M; Lazaro M; Magalon J; Veran J; Darque A; Grimaud F; Stolowy N; Beylerian H; Sabatier F; Hoffart L
J Fr Ophtalmol; 2018 Mar; 41(3):246-254. PubMed ID: 29602451
[TBL] [Abstract][Full Text] [Related]
7. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease.
Wang Y; Ogawa Y; Dogru M; Kawai M; Tatematsu Y; Uchino M; Okada N; Igarashi A; Kujira A; Fujishima H; Okamoto S; Shimazaki J; Tsubota K
Bone Marrow Transplant; 2008 Feb; 41(3):293-302. PubMed ID: 17982500
[TBL] [Abstract][Full Text] [Related]
8. Ocular surface evaluation in allogenic hematopoietic stem cell transplantation patients.
Vanathi M; Kashyap S; Khan R; Seth T; Mishra P; Mahapatra M; Tandon R
Eur J Ophthalmol; 2014; 24(5):655-66. PubMed ID: 24604604
[TBL] [Abstract][Full Text] [Related]
9. Treatment of severe chronic ocular graft-versus-host disease using 100% autologous serum eye drops from a sealed manufacturing system: a retrospective cohort study.
Tahmaz V; Gehlsen U; Sauerbier L; Holtick U; Engel L; Radojska S; Petrescu-Jipa VM; Scheid C; Hallek M; Gathof B; Cursiefen C; Steven P
Br J Ophthalmol; 2017 Mar; 101(3):322-326. PubMed ID: 27267447
[TBL] [Abstract][Full Text] [Related]
10. Ocular findings and ocular graft-versus-host disease after allogeneic stem cell transplantation without total body irradiation.
Pathak M; Diep PP; Lai X; Brinch L; Ruud E; Drolsum L
Bone Marrow Transplant; 2018 Jul; 53(7):863-872. PubMed ID: 29382955
[TBL] [Abstract][Full Text] [Related]
11. Tear Osmolarity and Ocular Surface Parameters as Diagnostic Markers of Ocular Graft-Versus-Host Disease.
Na KS; Yoo YS; Hwang KY; Mok JW; Joo CK
Am J Ophthalmol; 2015 Jul; 160(1):143-9.e1. PubMed ID: 25870935
[TBL] [Abstract][Full Text] [Related]
12. A plethora of ocular surface manifestations in a multidisciplinary ocular graft-versus-host disease unit.
Trindade M; Rodrigues M; Pozzebon ME; Aranha FJP; Colella MP; Fernandes A; Fornazari DO; de Almeida Borges D; Vigorito AC; Alves M
Sci Rep; 2022 Sep; 12(1):15926. PubMed ID: 36151252
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy evaluation of 0.05% cyclosporine A and 0.1% tacrolimus eye drops in the treatment of severe dry eye associated with chronic graft-versus-host disease].
Liu SW; Zhao YH; Ma J; Shen Z; Hu BH; Peng RM; Hong J
Zhonghua Yan Ke Za Zhi; 2023 Oct; 59(10):805-813. PubMed ID: 37805414
[No Abstract] [Full Text] [Related]
14. The application of autologous serum eye drops in severe dry eye patients; subjective and objective parameters before and after treatment.
Jirsova K; Brejchova K; Krabcova I; Filipec M; Al Fakih A; Palos M; Vesela V
Curr Eye Res; 2014 Jan; 39(1):21-30. PubMed ID: 24074049
[TBL] [Abstract][Full Text] [Related]
15. Antioxidant and inflammatory cytokine in tears of patients with dry eye syndrome treated with preservative-free versus preserved eye drops.
Jee D; Park SH; Kim MS; Kim EC
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):5081-9. PubMed ID: 24994869
[TBL] [Abstract][Full Text] [Related]
16. Baseline profiles of ocular surface and tear dynamics after allogeneic hematopoietic stem cell transplantation in patients with or without chronic GVHD-related dry eye.
Wang Y; Ogawa Y; Dogru M; Tatematsu Y; Uchino M; Kamoi M; Okada N; Okamoto S; Tsubota K
Bone Marrow Transplant; 2010 Jun; 45(6):1077-83. PubMed ID: 19898506
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of dry eye syndrome after allogeneic hematopoietic stem cell transplantation.
Ivanir Y; Shimoni A; Ezra-Nimni O; Barequet IS
Cornea; 2013 May; 32(5):e97-101. PubMed ID: 23187163
[TBL] [Abstract][Full Text] [Related]
18. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome.
Yoon KC; Heo H; Im SK; You IC; Kim YH; Park YG
Am J Ophthalmol; 2007 Jul; 144(1):86-92. PubMed ID: 17493572
[TBL] [Abstract][Full Text] [Related]
19. [Assessment of lipid layer thickness of tear film in the diagnosis of dry-eye syndrome in children after the hematopoietic stem cell transplantation].
Kurpińska M; Gorczyńska E; Owoc-Lempach J; Bernacka A; Misiuk-Hojło M; Chybicka A
Klin Oczna; 2011; 113(4-6):136-40. PubMed ID: 21913442
[TBL] [Abstract][Full Text] [Related]
20. Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye.
Yamane M; Ogawa Y; Fukui M; Kamoi M; Saijo-Ban Y; Yaguchi S; Mukai S; Kawakita T; Simmura S; Tsubota K
Optom Vis Sci; 2015 Apr; 92(4 Suppl 1):S25-32. PubMed ID: 25785527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
